Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients.

I Rivero-Belenchón,I Osmán-García,C B Congregado-Ruíz, P Cabrera-Roldán, M J Jiménez-Torres, M Baeza-Trujillo,G Lendínez-Cano,J M Conde-Sánchez,E Argüelles-Salido, M J Ortiz-Gordilo, R A Medina-López

Brachytherapy（2018）

引用 6|浏览13

暂无评分

摘要

LDR-BT is a feasible and acceptable treatment for localized PCa in RTRs. Oncological outcomes are similar to the GP, and there is minimal toxicity to the renal graft.

查看译文

关键词

Brachytherapy,Prostate cancer,Renal transplant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要